Which subgroup of rheumatoid arthritis patients benefits from switching to tocilizumab versus etanercept after previous infliximab failure? A retrospective study

✍ Scribed by Hiroki Wakabayashi; Masahiro Hasegawa; Yosuke Nishioka; Akihiro Sudo; Kusuki Nishioka

• Publisher: Springer
• Year: 2011
• Tongue: English
• Weight: 325 KB
• Volume: 22
• Category: Article
• ISSN: 1439-7595
• DOI: 10.1007/s10165-011-0485-9